Cooper Debt to Equity Ratio 2010-2024 | COO

Current and historical debt to equity ratio values for Cooper (COO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cooper debt/equity for the three months ending January 31, 2024 was 0.35.
Cooper Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-01-31 $4.34B $7.70B 0.56
2023-10-31 $4.11B $7.55B 0.54
2023-07-31 $4.17B $7.53B 0.55
2023-04-30 $4.16B $7.38B 0.56
2023-01-31 $4.23B $7.34B 0.58
2022-10-31 $4.32B $7.18B 0.60
2022-07-31 $4.47B $7.08B 0.63
2022-04-30 $4.76B $7.01B 0.68
2022-01-31 $4.74B $6.93B 0.68
2021-10-31 $2.66B $6.94B 0.38
2021-07-31 $2.83B $6.79B 0.42
2021-04-30 $2.85B $6.16B 0.46
2021-01-31 $2.93B $5.99B 0.49
2020-10-31 $2.91B $3.83B 0.76
2020-07-31 $2.99B $3.76B 0.80
2020-04-30 $2.88B $3.63B 0.80
2020-01-31 $2.82B $3.73B 0.76
2019-10-31 $2.65B $3.63B 0.73
2019-07-31 $2.56B $3.62B 0.71
2019-04-30 $2.66B $3.54B 0.75
2019-01-31 $2.87B $3.43B 0.84
2018-10-31 $2.81B $3.31B 0.85
2018-07-31 $3.03B $3.23B 0.94
2018-04-30 $3.23B $3.19B 1.01
2018-01-31 $3.11B $3.16B 0.99
2017-10-31 $1.68B $3.18B 0.53
2017-07-31 $1.69B $3.09B 0.55
2017-04-30 $1.81B $2.94B 0.62
2017-01-31 $1.84B $2.82B 0.65
2016-10-31 $1.78B $2.70B 0.66
2016-07-31 $1.86B $2.74B 0.68
2016-04-30 $1.86B $2.75B 0.68
2016-01-31 $1.80B $2.61B 0.69
2015-10-31 $1.79B $2.67B 0.67
2015-07-31 $1.73B $2.69B 0.64
2015-04-30 $1.78B $2.62B 0.68
2015-01-31 $1.82B $2.52B 0.72
2014-10-31 $1.87B $2.59B 0.72
2014-07-31 $0.69B $2.68B 0.26
2014-04-30 $0.66B $2.56B 0.26
2014-01-31 $0.66B $2.45B 0.27
2013-10-31 $0.71B $2.42B 0.30
2013-07-31 $0.57B $2.44B 0.23
2013-04-30 $0.63B $2.34B 0.27
2013-01-31 $0.72B $2.25B 0.32
2012-10-31 $0.73B $2.21B 0.33
2012-07-31 $0.79B $2.10B 0.38
2012-04-30 $0.59B $2.04B 0.29
2012-01-31 $0.66B $1.94B 0.34
2011-10-31 $0.69B $1.94B 0.36
2011-07-31 $0.73B $1.89B 0.39
2011-04-30 $0.82B $1.81B 0.45
2011-01-31 $0.85B $1.72B 0.49
2010-10-31 $0.86B $1.67B 0.52
2010-07-31 $0.91B $1.59B 0.57
2010-04-30 $0.97B $1.54B 0.63
2010-01-31 $0.97B $1.55B 0.63
2009-10-31 $1.01B $1.54B 0.66
2009-07-31 $1.07B $1.51B 0.71
2009-04-30 $1.12B $1.43B 0.78
2009-01-31 $1.17B $1.38B 0.85
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.860B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00